PWTYX
Price
$56.18
Change
+$0.05 (+0.09%)
Updated
Oct 17 closing price
Net Assets
225.58M
RLBCX
Price
$38.75
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

PWTYX vs RLBCX

Header iconPWTYX vs RLBCX Comparison
Open Charts PWTYX vs RLBCXBanner chart's image
UBS US Allocation P
Price$56.18
Change+$0.05 (+0.09%)
VolumeN/A
Net Assets225.58M
American Funds American Balanced R3
Price$38.75
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
PWTYX vs RLBCX Comparison Chart in %
View a ticker or compare two or three
VS
PWTYX vs. RLBCX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PWTYX is a Hold and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 265B vs. PWTYX (226M). PWTYX pays higher dividends than RLBCX: PWTYX (1.65) vs RLBCX (1.49). PWTYX was incepted earlier than RLBCX: PWTYX (32 years) vs RLBCX (23 years). RLBCX (0.89) is less costly to investors than PWTYX (0.77). PWTYX is a more actively managed with annual turnover of: 58.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than PWTYX: RLBCX (250) vs PWTYX (2000000). RLBCX annual gain was more profitable for investors over the last year : 8.34 vs. PWTYX (4.30). RLBCX return over 5 years is better than : 40.24 vs. PWTYX (9.23).
PWTYXRLBCXPWTYX / RLBCX
Total Expense Ratio0.770.8987%
Annual Report Gross Expense Ratio0.770.8987%
Fund Existence32 years23 years-
Gain YTD11.18114.36478%
Front LoadN/AN/A-
Min. Initial Investment2000000250800,000%
Min. Initial Investment IRAN/AN/A-
Net Assets226M265B0%
Annual Yield % from dividends1.651.49111%
Returns for 1 year4.308.3452%
Returns for 3 years33.0849.2667%
Returns for 5 years9.2340.2423%
Returns for 10 years50.3572.1870%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBM3.520.07
+2.03%
Psyence Biomedical Ltd
CVGW23.810.14
+0.59%
Calavo Growers
SWK67.85-0.06
-0.09%
Stanley Black & Decker
IQ2.03-0.03
-1.46%
iQIYI
PMVP1.40-0.04
-2.78%
PMV Pharmaceuticals